Dr. Devang J. Pastakia
Claim this profileVanderbilt University/Ingram Cancer Center
Studies Neuroblastoma
Studies Brain Tumor
8 reported clinical trials
18 drugs studied
Area of expertise
1Neuroblastoma
MYC negative
Stage IV
2Brain Tumor
Stage IV
Stage I
Stage II
Affiliated Hospitals
Clinical Trials Devang J. Pastakia is currently running
Selumetinib vs. Chemotherapy
for Brain Cancer
This trial is comparing a new drug, selumetinib, with standard chemotherapy to treat patients with a specific type of brain tumor. The patients do not have a certain genetic mutation and are not affected by a genetic disorder. Selumetinib works by blocking enzymes needed for tumor growth, while the standard drugs kill or stop tumor cells from dividing.
Recruiting2 awards Phase 3
DAY101
for Langerhans Cell Histiocytosis
This trial tests the safety and effectiveness of tovorafenib (DAY101) in children and young adults with Langerhans cell histiocytosis that is worsening, has returned, or does not respond to other treatments. Tovorafenib is taken orally and works by blocking enzymes needed for cancer cell growth. The study aims to find the best dose and observe the response and side effects over time.
Recruiting1 award Phase 228 criteria
More about Devang J. Pastakia
Clinical Trial Related4 years of experience running clinical trials · Led 8 trials as a Principal Investigator · 6 Active Clinical TrialsTreatments Devang J. Pastakia has experience with
- Cyclophosphamide
- Laboratory Biomarker Analysis
- Radiation Therapy
- Selumetinib
- Difluoromethylornithine (DFMO)
- Carboplatin
Breakdown of trials Devang J. Pastakia has run
Neuroblastoma
Brain Tumor
Ganglioneuroblastoma
Low Grade Glioma
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Devang J. Pastakia specialize in?
Devang J. Pastakia focuses on Neuroblastoma and Brain Tumor. In particular, much of their work with Neuroblastoma has involved MYC negative patients, or patients who are Stage IV.
Is Devang J. Pastakia currently recruiting for clinical trials?
Yes, Devang J. Pastakia is currently recruiting for 5 clinical trials in Nashville Tennessee. If you're interested in participating, you should apply.
Are there any treatments that Devang J. Pastakia has studied deeply?
Yes, Devang J. Pastakia has studied treatments such as Cyclophosphamide, Laboratory Biomarker Analysis, Radiation Therapy.
What is the best way to schedule an appointment with Devang J. Pastakia?
Apply for one of the trials that Devang J. Pastakia is conducting.
What is the office address of Devang J. Pastakia?
The office of Devang J. Pastakia is located at: Vanderbilt University/Ingram Cancer Center, Nashville, Tennessee 37232 United States. This is the address for their practice at the Vanderbilt University/Ingram Cancer Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.